Masimo | MASI - SCHULD

Aktienkurs
178.63
Täglich Wechseln
-0.08 -0.04%
Monatlich
0.30%
Jährlich
9.09%
Q2 Prognose
174.81




SCHULD Veränderung Datum
Abbott USD 13.86B 919M 2025-12
Accuray USD 170.24M 4.52M 2024-09
Align Technology USD 121.27M 1.75M 2025-09
AngioDynamics USD 6.3M 6.3M 2025-02
Artivion USD 317.78M 619K 2024-12
AtriCure USD 76.73M 521K 2025-09
Avanos Medical USD 133.7M 3.6M 2025-09
Baxter International USD 9.71B 13M 2025-09
Becton, Dickinson and Co. USD 19.54B 358M 2025-12
Boston Scientific USD 11.44B 610M 2025-12
Dexcom USD 1.24B 1.21B 2025-12
Edwards Lifesciences USD 600M 105.4M 2026-03
General Electric Aerospace USD 20.28B 217M 2026-03
Globus Medical USD 119.34M 1.76M 2025-09
Haemonetics USD 1.22B 54K 2025-09
Inogen USD 0 0 2022-06
Insulet USD 1.01B 384.9M 2025-09
Integra LifeSciences USD 2.01B 7.91M 2025-09
Intuitive Surgical USD 0 0 2025-03
Masimo USD 586.2M 56M 2025-09
Medtronic USD 28.07B 1.03B 2025-12
Orthofix International USD 137.23M 338K 2024-09
Owens Minor USD 1.95B 91.18M 2025-03
ResMed USD 846.35M 178.06M 2025-09
Steris USD 2.06B 10.4M 2025-09
Stryker USD 14.86B 1.74B 2025-12
Tandem Diabetes Care USD 449.28M 276K 2025-09
Teleflex USD 2.77B 774M 2025-09
Thermo Fisher Scientific USD 39.39B 3.7B 2025-12
Zimmer Biomet Holdings USD 7.52B 593.5M 2025-12